Regional moderate hyperthermia for mild-to-moderate COVID-19 (TherMoCoV study): a randomized controlled trial.
Mancilla-Galindo J, Kammar-García A, Mendoza-Gertrudis ML, García Acosta JM, Nava Serrano YS, Santiago O, Torres Vásquez MB, Martínez Martínez D, Fernández-Urrutia LA, Robledo Pascual JC, Narváez Morales ID, Velasco-Medina AA, Mancilla-Ramírez J, Figueroa-Damián R, Galindo-Sevilla N.
Mancilla-Galindo J, et al. Among authors: kammar garcia a.
Front Med (Lausanne). 2023 Dec 22;10:1256197. doi: 10.3389/fmed.2023.1256197. eCollection 2023.
Front Med (Lausanne). 2023.
PMID: 38188344
Free PMC article.